Invention Grant
- Patent Title: Reversible di-nucleotide terminator sequencing
- Patent Title (中): 可逆二核苷酸终止子测序
-
Application No.: US13198901Application Date: 2011-08-05
-
Publication No.: US08715938B2Publication Date: 2014-05-06
- Inventor: Gerald Zon
- Applicant: Gerald Zon
- Applicant Address: US CA Carlsbad
- Assignee: Life Technologies Corporation
- Current Assignee: Life Technologies Corporation
- Current Assignee Address: US CA Carlsbad
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12P19/34 ; C07H21/04

Abstract:
The present teachings provide methods, compositions, and kits for synthesizing and sequencing nucleic acids. In some embodiments, reversible di-nucleotide compounds are employed along with cleaving reactions that remove a label and a blocking moiety. Improved sequencing efficiency is achieved by the rapid polymerase-mediated incorporation of reversible di-nucleotide compounds. In some embodiments, the di-nucleotides do not contain conventional nucleotide triphosphates, but rather employ amino acid phosphoramidate nucleotides (AAPNs).
Public/Granted literature
- US20130065225A1 Reversible Di-Nucleotide Terminator Sequencing Public/Granted day:2013-03-14
Information query